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Seizure Disorders in Goats and Sheep
M. Chigerwe and M. Aleman
Background: Goats and sheep are more likely to be presented for examination for seizures than are cattle, possibly as a
consequence of their relatively smaller body size. Currently, no reports describing seizure disorders in goats and sheep are
available.
Objectives: To describe clinical features and treatment outcomes of sheep and goats presented for seizures.
Animals: A total of 59 goats and 21 sheep presented for seizures.
Methods: Retrospective study. Medical records from 1994 to 2014 at the Veterinary Medical Teaching Hospital, Univer-
sity of California, Davis, were reviewed. Descriptive statistics were used to summarize data. Logistic regression was
performed to determine whether variables were associated with mortality.
Results: The majority of seizures in goats and sheep had structural or metabolic causes. Polioencephalomalacia
(PEM) secondary to ruminal lactic acidosis or PEM of undetermined cause was the most frequently diagnosed cause of
seizures in goats and sheep. The proportions of mortality in goats and sheep were 49.2 and 42.9%, respectively.
Age increased the odds mortality (odds ratio [OR], 1.51; 95% confidence interval [CI], 1.07, 2.14) in goats. Goats
with structural or metabolic causes of seizures had higher odds for mortality (OR, 37.48; 95% CI, 1.12, 99.10) than those
with unknown causes. Age and etiological diagnosis were not significant (P > .05) predictors of mortality in affected
sheep.
Conclusions and Clinical Relevance: Seizure disorders in goats and sheep are associated with high mortality, despite treat-
ment. Current treatment in goats and sheep with seizures warrants further investigation to determine whether treatments are
beneficial or detrimental to survival.
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A seizure is defined as a transient occurrence ofphysical signs with a finite duration, a tendency to
begin and end abruptly, and caused by abnormal exces-
sive or synchronous neuronal activity in the brain.1
These neuronal paroxysmal discharges can be detected
by clinical manifestations, electroencephalographic
recording, or both. Epilepsy is a complex chronic disor-
der of the brain characterized by recurrent seizures
caused by a variety of pathological processes.1 Accord-
ing to the International League Against Epilepsy
(ILAE), seizures are classified as genetic, structural or
metabolic, and unknown, based on etiology.2,3 Further
classification of epilepsy has been determined through
clinical manifestations and electroencephalography
(EEG) recordings.2–4 Seizures can manifest as localized,
generalized, or non-motor (psychic or behavioral, auto-
nomic).5 Recently, a consensus report on epilepsy
definition, classification, and terminology was published
in veterinary medicine.6
In a retrospective study of 43 beef cattle, most sei-
zures were classified as reactive (70%), and the underly-
ing cause was identified in the majority of cases.7
Causes of seizures in cattle included metabolic disor-
ders, cerebral cortical necrosis, inflammatory or infec-
tious, and intoxications.7 In ruminants, muscle
contractions during a seizure episode can cause the ani-
mal to fall down, compromising the safety of the han-
dler during examination or transportation. Sheep and
goats are relatively smaller in size compared to cattle;
thus, on-farm examination or transportation to a veteri-
nary clinic is more feasible. Consequently, it is antici-
pated that sheep and goats experiencing seizures are
more likely to be presented for examination compared
to cattle.
Currently, studies describing seizure disorders in
goats and sheep are not available. The objective of our
retrospective study was to describe the clinical features
and treatment outcomes of sheep and goats presented
for seizures.
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Materials and Methods
Medical records of goats and sheep presented to the William P.
Pritchard Veterinary Medical Teaching Hospital (VMTH), Univer-
sity of California, Davis, from 1994 to 2014 were reviewed. Inclu-
sion criteria included goats and sheep with seizures based on
evaluation by a VMTH clinician or a referring veterinarian. Data
collected included signalment, physical examination findings, neu-
rological examination findings, diagnostic test findings, clinical or
definitive diagnosis, medical treatments, and treatment outcomes.
Goat breeds were classified as meat or dairy (Alpine, Boer, Cash-
mere, Kiko, Lamancha, Nubian, Oberhasli, San Clemente, Span-
ish, and Toggenburg), dwarf (pygmy or dwarf Nigerian), or other
(Tennessee fainting). Sheep breeds were classified as meat or dairy
breeds (Barbados, Hampshire, Jacob, Shetland, Shropshire,
Suffolk) or other (Bighorn).
Diagnostic tests performed included CBC, serum biochemical
analysis, blood culture, cerebrospinal fluid (CSF) analysis, toxicologi-
cal analysis, rumen fluid analysis, fecal examination, immunological
analysis, radiographic examination, ultrasonographic examination,
computed tomography (CT), magnetic resonance imaging (MRI),
electroencephalography (EEG), and necropsy.
Etiological diagnosis of seizures was classified as genetic, struc-
tural or metabolic, and unknown.2,3 This seizure classification2,3
was considered more applicable to goats and sheep compared to
the companion animal classification.6 Treatment outcome was con-
sidered as discharged alive, euthanized, or died. Animals that
received treatment before presentation to the VMTH or had sei-
zures observed by the client only were excluded from the study.
Statistical Analysis
Descriptive statistics were used to summarize the data. Propor-
tions of occurrence of seizures among goat breeds were assessed
using a chi-square or Fisher exact test. Logistic regression predicting
mortality (death or euthanasia) was performed for goats with age,
breed, medical treatments, and etiological diagnosis of the seizures
as independent variables. In the logistic regression model for sheep,
age and etiological diagnosis of the seizures were considered as inde-
pendent variables. Breed was excluded as a variable because only 2
sheep were classified as other breeds. Genetic etiological diagnosis
was excluded because none of the goats or sheep were diagnosed
with genetic cause of seizures. Effect of treatment in the logistic
regression analysis for sheep was excluded because all were medi-
cally treated. A variable was considered to be significantly associated
with mortality if the OR was >1 with a corresponding P < .05.
Model assessment was performed using the Hosmer and Lemeshow
goodness-of-fit test. For all statistical analysis, a commercial statisti-
cal softwarea was used. P < .05 was considered significant.
Results
Fifty-nine goats and 21 sheep met the inclusion criteria
representing 1.9% of sheep and goats presented to the
VMTH during the same time period. Median (range) age
for goats was 1 year (1 day – 12 years) and 1 year for
sheep (7 days – 10 years). Age was not indicated in the
medical record for 7 goats and 2 sheep. Forty-three
(72.9%) goats were of the meat or dairy breed, 14
(23.7%) were pygmy or dwarf Nigerian, and 2 (3.4%)
were classified as other breed. In goats, proportion of
meat or dairy breeds was overrepresented (P < .0001)
compared to pygmy or dwarf Nigerian or other breeds.
Nineteen (90.5%) of sheep included were of the meat or
dairy breed and 2 (9.5%) were classified as other breed.
The proportion of sheep meat or dairy breeds was over-
represented (P < .0001) compared to other breeds.
Diagnostic tests performed singly or in combination
for diagnosis of the cause of seizures in goats and sheep
after physical and neurological examination are summa-
rized in Table 1. Polioencephalomalacia (PEM, cerebro-
cortical necrosis) of undetermined cause was considered
a tentative diagnosis in goats and sheep that presented
with (1) neurological signs consistent with forebrain dis-
ease, (2) response to therapeutic doses of thiamine
hydrochloride, and, when available, (3) an unremark-
able or mild mononuclear pleocytosis with increased in
protein concentration on CSF analysis.8–10 The etiologi-
cal diagnoses of seizures are summarized in Table 2.
Seizures due to hypoglycemia in goats were diagnosed
in neonates (<6 weeks old) with hypoglycemia sec-
ondary failure to nurse during the first 48 hours after
birth (3 cases) and severe diarrhea caused by helminthi-
asis (2 cases). Seizures secondary to hypoglycemia in
the single sheep case was a 7-day-old lamb that failed
to nurse because of recumbency. Diagnosis was made at
necropsy for goats and sheep diagnosed with meningitis,
brain abscesses, leukoencephalomalacia, meningoepithe-
lial hyperplasia, systemic sarcosporidiosis, and heredi-
tary myelinopathy. Trueperella pyogenes, (2 cases),
Corynebacterium pseudotuberculosis (2 cases), Strepto-
coccus sp (1 case), and Actinomyces sp (1 case) were
cultured from brain abscesses in goats. Leukoen-
cephalomalacia of the cerebral cortex associated with
vasculitis secondary to sepsis caused by Escherichia coli
metritis (1 case) and vasculitis of undetermined cause
(1 case) were reported in 2 cases (Table 2).
Paroxysmal discharges (spikes and waves, sharp
waves) supportive of epileptic activity were visualized
Table 1. Diagnostic tests performed singly, or in com-
bination, as part of the diagnosis of the cause of sei-
zures in goats and sheep (N = 59 goats; N = 21 sheep).
CSF = cerebrospinal fluid, CT = computed tomogra-
phy, EEG = electroencephalography, MRI = magnetic
resonance imaging.
Diagnostic Test Performed
Proportion of Patients with
Diagnostic Test Performed % (N)
Goats Sheep
CBC 37.2 (22/59) 42.9 (9/21)
Chemistry 94.9 (56/59) 23.8 (5/21)
Fecal flotation 16.9 (10/59) 4.8 (1/21)
Radiographs 10.2 (6/59) 9.5 (2/21)
Ultrasound 5.1 (3/59) 0 (0/21)
CSF analysis 10.2 (6/59) 14.3 (3/21)
Rumen fluid analysis 3.4 (2/59) 0 (0/21)
Toxicology 3.4 (2/59) 9.5 (2/21)
CT Scan 0 (0/59) 4.8 (1/21)
MRI 3.4 (2/59) 0 (0/21)
EEG 10 (6/59) 0 (0/21)
Blood culture 0 (0/59) 4.8 (1/21)
Viral isolation 0 (0/59) 4.8 (1/21)
Necropsy 44.1 (26/59) 42.9 (9/21)
No test performed 1.7 (1/59) 0 (0/21)
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on EEG recordings in 5 of 6 goats. The results of the
MRI (pre- and post-contrast) in 2 goats indicated corti-
cal atrophy with ventricular dilatation and synovial dis-
tension of the right atlanto-occipital joint in 1 case but
were unremarkable in the second case. In the single
sheep case, contrast CT of the brain indicated increased
attenuation associated with the right parietal lobe.
Medical treatment included IV fluids, thiamine (IM or
IV), parenteral antibiotics (penicillins, tetracyclines,
cephalosporins, and macrolides), diuretics (furosemide,
mannitol), nonsteroidal anti-inflammatory drugs
(NSAID flunixin meglumine), corticosteroids (dexam-
ethasone), anticonvulsants (diazepam), D-penicillamine,
and intranasal oxygen. Diazepam was administered IV
or IM at 0.5–1.5 mg/kg to control seizures. Medical
therapies performed in goats and sheep are summarized
in Table 3. Proportions (%) of goats and sheep that died
or were euthanized during hospitalization were 49.2 (29/
59) and 42.9% (9/21), respectively.
Logistic regression predicting probability of mortality
(death or euthanasia) in goats is summarized in
Table 4. Age increased the odds of mortality (OR, 1.51;
95% CI, 1.07, 2.14; P = .004) in goats. Goats diagnosed
with structural or metabolic causes of seizures had
higher odds for mortality (OR, 37.48; 95% CI, 1.12,
99.10; P = .003) compared to those diagnosed with
unknown causes. Goat breed (P = .845) and treatment
(P = .273) were not significant predictors of mortality.
The logistic regression model for goats was a good fit
(P = .413). The logistic regression predicting mortality
in sheep is summarized in Table 5. Age (P = .293) and
etiological diagnosis (P = .416) were not significant pre-
dictors of mortality in sheep.
Discussion
The majority of causes of seizures in both goats and
sheep were classified as structural or metabolic. Within
the structural or metabolic classification, PEM sec-
ondary to ruminal lactic acidosis or PEM of undeter-
mined cause was the most common disease condition
diagnosed. The relatively higher proportion of diagnosis
of PEM of undetermined cause or secondary to ruminal
Table 2. Causes of seizures in goats and sheep (N = 59
goats; N = 21 sheep). PEM = polioencephalomalacia,
CNS = central nervous system.
General
Etiological
Diagnosis Specific Etiology
Goats
% (N)
Sheep
% (N)
Structural/
metabolic
Genetic
PEM secondary to
ruminal lactic acidosis
22.0 (13/59) 1.7 (1/21)
aPEM—undetermined
cause
18.6 (11/59) 57.1 (12/21)
Hypoglycemia 8.5 (5/59) 4.8 (1/21)
Hypernatremia 3.4 (2/59) 4.8 (1/21)
Meningitis 8.5 (5/59) 9.5 (2/21)
Trauma 1.7 (1/59) 4.8 (1/21)
Cortical thermal
necrosis secondary
to disbudding
1.7 (1/59) 0 (0/21)
Nervous coccidiosis 3.4 (2/59) 0 (0/21)
Brain abscess 10.2 (6/59) 0 (0/21)
Copper intoxication 1.7 (1/59) 9.5 (2/21)
Bronchopneumonia 1.7 (1/59) 0 (0/21)
Leukoencephalomalacia 3.4 (2/59) 0 (0/21)
Meningoepithelial
hyperplasia
1.7 (1/59) 0 (0/21)
Systemic
sarcosporidiosis
1.7 (1/59) 0 (0/21)
Suspected hereditary
CNS spongiform
myelinopathy
1.7 (1/59) 0 (0/21)
bUnknown Undetermined 10.2 (6/59) 9.5 (1/21)
Genetic 0/59 0/59
aA tentative diagnosis of PEM of undetermined cause was made
in sheep and goats with neurological signs consistent with forebrain
disease, responded to therapeutic doses of thiamine hydrochloride,
and when available, an unremarkable or mild mononuclear pleocy-
tosis with increase in protein of CSF analysis.8–10
bThe etiological diagnosis of “Unknown” causes of seizures con-
sisted of cases in which the diagnosis was not made from ante-
mortem and or postmortem diagnostic tests.
Table 3. Medical therapies performed singly, or in com-
bination, as part of management in goats and sheep with
seizures (N = 59 goats; N = 21 sheep). NSAID = Nons-
teroidal anti-inflammatory drugs.
Medical Treatment
Proportion of Patients with Medical
Therapies Performed % (N)
Goats Sheep
IV fluids 74.6 (44/59) 85.7 (18/21)
Thiamine 71.2 (42/59) 81.0 (17/21)
Diazepam 62.7 (37/59) 52.4 (11/21)
Antibiotics 57.6 (34/59) 61.9 (13/21)
Mannitol 20.3 (12/59) 38.1 (8/21)
NSAID—flunixin meglumine 13.6 (8/59) 4.8 (1/21)
Corticosteroids 8.5 (5/59) 9.5 (2/21)
Intranasal oxygen 5.1 (3/59) 4.8 (1/21)
Phenobarbital (oral) 3.9 (2/59) 0 (0/21)
Furosemide 1.7 (1/59) 0 (0/21)
Vitamin/selenium 1.7 (1/59) 0 (0/21)
Blood transfusion 0 (0/59) 4.8 (1/21)
D-penicillamine 1.7 (1/59) 4.8 (1/21)
Ammonium molybdate 0 (0/59) 9.5 (2/21)
Clostridium tetani antitoxin 1.7 (1/59) 0 (0/21)
Fenbendazole 0 (0/59) 4.8 (1/21)
No treatment performed 3.4 (2/59) 0 (0/21)
Table 4. Logistic regression predicting mortality in
goats as a function of age, breed, general etiological
diagnosis, and treatment (N = 59), 95% CI—95% con-
fidence interval.
Variable Estimate (95% CI)
Odds Ratio
(95% CI)
P
value
Intercept 0.635 (0.352, 1.623) – .207
Age 0.069 (0.116, 0.022) 1.51 (1.07, 2.13) .004
Breed 0.030 (0.236, 0.266) 1.03 (0.21, 5.14) .845
Etiological
diagnosis
0.537 (0.894, 0.179) 37.48 (1.12, 99.10) .003
Treatment 0.485 (0.381, 1.352) 0.01 (0.001, 9.02) .273
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lactic acidosis in our study might be due to overrepre-
sentation of meat or dairy breeds. Meat or dairy breeds
are more likely to be raised for increased average daily
weight gain or milk production and thus are exposed to
risk factors for PEM, such as high-carbohydrate diets.
The term PEM has been used in reference to softening
of the gray matter of the brain, attributed to altered thi-
amine metabolism, hypernatremia, lead poisoning or
high sulfur intake.11 The term polioencephalomalacia
also might be used in reference to any neurologic disease
syndrome associated with an altered thiamine status.11
Ruminal lactic acidosis results in decreased ruminal thi-
amine synthesis, increased thiaminase-producing bacteria
(Clostridium sporogenes and Bacillus spp),12–14 and
decreased activity of the thiamine diphosphate-dependent
enzyme transketolase.15,16 Transketolase is the rate-
limiting enzyme in the pentose phosphate pathway, which
is required for energy metabolism in nervous tissue.17
The relationship between PEM and thiamine is uncer-
tain.18 Although earlier studies reported sheep and cattle
to be in a state of thiamine deficiency,10 other studies
reported no alterations in blood thiamine concentrations
between cattle with PEM and those with other neurologic
diseases.19 Additionally, increased concentrations of
rumen hydrogen sulfide, with no alterations in thiamine
concentrations, were observed during peak PEM occur-
rence in steers.20 In our study, diagnosis of PEM sec-
ondary to ruminal lactic acidosis was based on history,
physical examination findings, serum biochemical analy-
sis, rumen fluid analysis, and necropsy. Previous reports
indicate that response to therapeutic doses of thiamine in
cattle or sheep with sulfur-induced PEM were vari-
able.21–23 Hence, non-responsiveness to thiamine treat-
ment does not rule out an antemortem diagnosis of
PEM. Consequently, cases of PEM in our study might
have been misdiagnosed if they did not respond to
thiamine administration.
Copper toxicosis causes intravascular hemolysis lead-
ing to tissue hypoxia (including the brain), and spongy
degeneration of the pons and brainstem leading to sei-
zure activity.24 Severe bronchopneumonia can cause tis-
sue hypoxia, which can lead to seizures. Hereditary
central nervous system spongiform myelinopathy was
reported in 1 pygmy goat in our study. Spongiform
myelinopathy has been reported in African dwarf goats
and results in spongy changes in the white and gray
matter of the cerebral cortex, leading to seizure activ-
ity.25 Meningoepithelial hyperplasia reported in 1 goat
in our study could have caused seizure activity due to
the pressure exerted on the cerebral cortex. Sarcocystis
sp was identified in the brain, lungs, kidneys, rumen,
and heart in 1 case (4-month-old Boer) in our study.
The prevalence of intramuscular Sarcocystis in goats
and sheep has been estimated at 52–79 and 18–100%,
respectively.26 However, reports of systemic sar-
cosporidiosis in small ruminants are unavailable in the
literature. The mechanism by which coccidiosis causes
neurological signs, including seizures, is not clearly
understood.27 Bacteria isolated from the brain abscesses
in goats in our study were Gram-positive anaerobes,
consistent with previous studies in cattle.28
Complete blood cell count and serum biochemical
analysis were the 2 most commonly performed ante-
mortem diagnostic tests. This finding is most likely as a
result of easy of collection of blood samples, fast turn-
around of results, and generation of information useful
as guidance for choice of supportive treatment, such as
IV fluids. Interestingly, CSF collection and analysis was
only performed in a small proportion of goats and
sheep, despite presentation of patients for seizures.
Rumen fluid analysis was only performed in 2 cases
despite 22% (13/59) of goats diagnosed with PEM sec-
ondary to ruminal lactic acidosis. This is most likely
because the history and physical examinations were suf-
ficient to make a diagnosis of PEM secondary to rumi-
nal lactic acidosis.
Intravenous fluids, thiamine, diazepam, and antibiotics
were the most commonly administered medications in
this study. The higher frequency of administration of thi-
amine while awaiting diagnostic test results in this study
might be a result of the higher frequency of differential
diagnoses that cause seizures by interfering with thiamine
metabolism in sheep and goats. Diazepam has been rec-
ommended to control seizures in ruminants8 and was the
most commonly used short-term anticonvulsant treat-
ment in our study. In 2 goats (Table 3), with undeter-
mined cause of seizures, phenobarbital was administered
PO for long-term management of seizures. Because of a
lack of studies in the literature on the pharmacokinetics
and pharmacodynamics of phenobarbital in goats for sei-
zure management, the dosage and frequency of dosing of
phenobarbital was based on response to treatment and
assessment of blood concentrations of phenobarbital,
once treatment was initiated. Furthermore, therapeutic
concentrations for any anticonvulsant in ruminants are
unknown.
Mannitol and furosemide were administered to
decrease brain edema in our study. Hyperosmolar treat-
ment (mannitol or hypertonic saline) has been used in
human29–33 and in veterinary medicine34 to decrease
brain edema. Evidence of effectiveness of mannitol,
hypertonic saline, or furosemide to decrease cerebral
edema associated with neurologic disease causing sei-
zures in goats and sheep is lacking. Use of an NSAID,
nimesulide, decreased prostaglandin E2 concentrations
in a thiamine deficiency rat model (Wernicke’s
encephalopathy).35 However, rather than being neuro-
protective, administration of nimesulide precipitated
encephalopathy and exacerbated neuronal death due to
Table 5. Logistic regression predicting mortality in
sheep as a function of age, general etiological diagnosis,
and treatment (N = 21), 95% CI—95% confidence
interval.
Variable Estimate (95% CI)
Odds Ratio
(95% CI)
P
value
Intercept 0.753 (0.442, 1.064) – <.0001
Age 0.046 (0.132, 0.040) 1.244 (0.787, 1.968) .293
Etiological
diagnosis
0.175 (0.60, 0.246) 2.229 (0.321, 15.485) .416
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thiamine deficiency.35 Reviews of the use of an NSAID
in humans with neurodegenerative diseases indicated
that inflammation in the brain was complex and admin-
istration of NSAID might not be beneficial.36 Evidence
to support the benefit of NSAID use in goats and sheep
with neurologic disease also is lacking. Administration
of dexamethasone at 0.04 mg/kg q24h for 3 consecutive
days suppressed neutrophil function in cattle.37 Effects
of dexamethasone in inflammatory conditions leading
to seizures in ruminants are unknown. Ammonium
molybdate and D-penicillamine were administered as
specific antidotes for copper toxicosis.24
Mortality reported in our study was relatively high in
both goats (49.2%) and sheep (42.9%) compared to
beef cattle with seizure disorders (16.3%).7 The odds
(OR = 1.5) of mortality increased with age. Although
goats diagnosed with structural or metabolic causes of
seizures had higher odds for mortality (OR = 37.48),
the 95% CI of the estimate was wide (1.12–99.10) sug-
gesting that the variable estimate was not precise.
Limitations of this study include information bias
because case selection was based on medical records.
Although not available in this study, CSF protein analy-
sis can be performed by the Pandy reaction38 whereas cell
count analysis can be performed by a Fuchs-Rosenthal
chamber, at a cost-effective price.39 Additionally, cases
with historical seizures or seizures not witnessed by a
veterinarian were excluded. The results of our study are
from a single institution and might have limited external
validity. Finances, client compliance, and clinician
expertise also could have been confounding factors for
mortality.
The majority of causes of seizures in goats and sheep
were classified as structural or metabolic. Polioen-
cephalomalacia secondary to ruminal lactic acidosis or
PEM of undetermined cause was the most frequently
diagnosed cause of seizures. Mortality associated with
diseases causing seizure disorders was high in goats and
sheep despite treatment.
Footnote
a SAS 9.4 Version, Cary, NC
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